Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Thyroid Neoplasms 2Neuroendocrine Tumors 2Primary Breast Cancer 1Parkinson Disease 1Malignancy of Thyroid Nodules 1Adenocarcinoma, Follicular 1

Interventions

Magnetic Resonance Spectroscopy 9Iodine-131 8Thyrotropin Alfa 5trametinib 3lenvatinib 3cabozantinib 3X-Rays 3Sunitinib 3Specimen Handling 3Fluorodeoxyglucose F18 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3vandetanib 2dabrafenib 2Trastuzumab 2Sorafenib 2Rosiglitazone 2Radiotherapy 2Interviews as Topic 2Gefitinib 2Everolimus 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tremelimumab 1tipifarnib 1tanespimycin 1spartalizumab 1selpercatinib 1sargramostim 1romidepsin 1pembrolizumab 1pazopanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Follicular × Iodine-123 × Clear all
NCT05591092 2025-04-22

Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery

Mayo Clinic

Completed
2 enrolled

Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡